Yanping is a Research Analyst at Vestal Point. Before joining Vestal Point, she was a Point72 Academy Associate.

Prior to Point72, Yanping was a Research Scientist at Houston Methodist Research Institute from 2023 to 2026, where she focused on the development and clinical translation of cancer immunotherapies. From 2021 to 2023, she served as an Instructor of Biomedical Engineering at Weill Cornell Medical College, following her postdoctoral training at Weill Cornell from 2017 to 2021.

Yanping earned a Ph.D. in Inorganic Chemistry and a B.S. in Chemistry from Beijing Normal University.